CIK 0001490978
- Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954284541
- Phone
- +1 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-10 | BILL & MELINDA GATES FOUNDATION TRUST 10% owner | Conversion · Series C preferred stock | −47,242,235 | 0 | ||
| 2020-02-10 | BILL & MELINDA GATES FOUNDATION TRUST 10% owner | Conversion · Series D preferred stock | −35,946,010 | 0 | ||
| 2020-02-10 | BILL & MELINDA GATES FOUNDATION TRUST 10% owner | Conversion · Series E preferred stock | −33,543,539 | 0 | ||
| 2020-02-10 | BILL & MELINDA GATES FOUNDATION TRUST 10% owner | Conversion · Limited common stock | +13,164,193 | 13,164,193 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion | +14,890,845 | 14,890,845 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion | +1,133,158 | 1,133,158 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion | +467,889 | 467,889 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion | +4,264 | 4,264 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion · Series A Preferred Stock, $0.01 par value per share | −111,314,131 | 0 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion · Series A Preferred Stock, $0.01 par value per share | −8,470,745 | 0 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion · Series A Preferred Stock, $0.01 par value per share | −3,497,635 | 0 | ||
| 2020-02-10 | SHAW DAVID E 10% owner | Conversion · Series A Preferred Stock, $0.01 par value per share | −31,878 | 0 | ||
| 2020-02-10 | Flynn James E 10% owner | Conversion | +1,346,167 | 1,346,167 | ||
| 2020-02-10 | Flynn James E 10% owner | Purchase | +250,000 | $17.00 | $4.3M | 250,000 |
| 2020-02-10 | Flynn James E 10% owner | Conversion · Series E Preferred Stock | −10,063,061 | 0 | ||
| 2020-02-10 | Abel Robert Lorne EVP, Science | Grant or award · Stock Option (right to buy) | +133,773 | 133,773 | ||
| 2020-02-10 | Kapeller-Libermann Rosana Director | Grant or award · Stock Option (right to buy) | +12,909 | 12,909 | ||
| 2020-02-10 | Lynton Michael Director | Grant or award · Stock Option (right to buy) | +12,909 | 12,909 | ||
| 2020-02-10 | Brauner Shane | Grant or award · Stock Option (right to buy) | +53,509 | 53,509 | ||
| 2020-02-10 | Tran Yvonne | Grant or award · Stock Option (right to buy) | +200,659 | 200,659 |
Page 59 of 60 · 1,192 trades